These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dissociation between lymphocyte activation for proliferation and for the capacity to adoptively transfer uveoretinitis. Fox GM, Redmond TM, Wiggert B, Kuwabara T, Chader GJ, Gery I. J Immunol; 1987 May 15; 138(10):3242-6. PubMed ID: 3106477 [Abstract] [Full Text] [Related]
24. [Experimental autoimmune uveoretinitis and pinealitis in Lewis rats induced by varied doses of interphotoreceptor retinoid-binding protein]. Yang PZ. Zhonghua Yan Ke Za Zhi; 1993 Nov 15; 29(6):373-6. PubMed ID: 8020385 [Abstract] [Full Text] [Related]
29. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Xu H, Rizzo LV, Silver PB, Caspi RR. Cell Immunol; 1997 May 25; 178(1):69-78. PubMed ID: 9184700 [Abstract] [Full Text] [Related]
31. Serial adoptive transfer of experimental autoimmune uveoretinitis in rats. Hu LH, Sanui H, Wiggert B, Redmond TM, Chan CC, Chader GJ, Gery I. Invest Ophthalmol Vis Sci; 1990 Jul 25; 31(7):1409-12. PubMed ID: 2365573 [Abstract] [Full Text] [Related]
32. Suppression of spontaneous uveoretinitis development by non-immunopathogenic peptide immunization. Takeuchi M, Kezuka T, Inoue H, Sakai J, Usui M, Takahashi T, Taguchi O. Eur J Immunol; 1998 May 25; 28(5):1578-86. PubMed ID: 9603463 [Abstract] [Full Text] [Related]
33. Immune responses to peptides derived from the retinal protein IRBP: immunopathogenic determinants are not necessarily immunodominant. Redmond TM, Sanui H, Hu LH, Wiggert B, Margalit H, Berzofsky JA, Chader GJ, Gery I. Clin Immunol Immunopathol; 1989 Nov 25; 53(2 Pt 1):212-24. PubMed ID: 2477180 [Abstract] [Full Text] [Related]
34. The existence of two completely distinct antigenic sites within a decapeptide. Kotake S, Sasamoto Y, Kawano Y, Sanui H, Wiggert B, Chader GJ, Gery I. Cell Immunol; 1992 Mar 25; 140(1):123-9. PubMed ID: 1371240 [Abstract] [Full Text] [Related]
35. CpG-containing oligodeoxynucleotide 1826 converts the weak uveitogenic rat interphotoreceptor retinoid-binding protein peptide 1181-1191 into a strong uveitogen. Shao H, Lei S, Sun SL, Xiang J, Kaplan HJ, Sun D. J Immunol; 2003 Nov 01; 171(9):4780-5. PubMed ID: 14568955 [Abstract] [Full Text] [Related]
38. The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis. Mizrahi T, Hauben E, Schwartz M. J Immunol; 2002 Nov 15; 169(10):5971-7. PubMed ID: 12421983 [Abstract] [Full Text] [Related]
39. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein. Hara Y, Caspi RR, Wiggert B, Chan CC, Wilbanks GA, Streilein JW. J Immunol; 1992 Mar 15; 148(6):1685-92. PubMed ID: 1531843 [Abstract] [Full Text] [Related]
40. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye. Wildner G, Thurau SR. Eur J Immunol; 1995 May 15; 25(5):1292-7. PubMed ID: 7774632 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]